BioCryst Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
BioCryst Pharma (BCRX) Reports In-Line Q3 EPS, Offers Outlook
November 5, 2015 7:59 AM ESTBioCryst Pharma (NASDAQ: BCRX) reported Q3 EPS of ($0.20), in-line with the analyst estimate of ($0.20). Revenue for the quarter came in at $11 million versus the consensus estimate of $6.77 million.
Financial Outlook for 2015
Based upon current trends, assumptions, and development plans,... More
